Noble Analytical Lab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 3.70 M
About Noble Analytical Lab
Noble Analytical Lab Private Limited (NALPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 January 2014 and has a history of 11 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Karam Verma and Sumit Kumar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24303DL2014PTC263443
- Company No.
263443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Noble Analytical Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Kumar  | Director | 28-Mar-2015 | Current |
| Karam Verma | Director | 13-Jan-2014 | Current |
Financial Performance of Noble Analytical Lab.
Noble Analytical Lab Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Noble Analytical Lab?
In 2017, Noble Analytical Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rapross Pharmaceuticals Private LimitedKaram Verma is a mutual person
Charges (Loans)
₹0
₹3.70 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2014 | Canara Bank | ₹3.70 M | Satisfied |
How Many Employees Work at Noble Analytical Lab?
Unlock and access historical data on people associated with Noble Analytical Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Analytical Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Analytical Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
